Magnacet

Magnacet is a narcotic medication licensed for the treatment of moderate to moderately severe pain. It is a combination product that contains two different drugs (acetaminophen and oxycodone) that work together to control pain. Magnacet comes in tablet form and is usually taken every six hours as needed for pain. While most people tolerate this medication well, potential side effects include drowsiness, nausea, and constipation.

 

What Is Magnacet?

Magnacet™ (oxycodone/APAP) is a prescription narcotic medication approved to treat moderate to moderately severe pain. This medication, like all oxycodone/APAP products, is not appropriate for very severe pain.
 
Because Magnacet is a narcotic, it is classified as a Schedule II controlled substance in the United States. This means that there are special laws and regulations for the prescribing, sale, and use of Magnacet. Schedule II controlled substances have the highest abuse potential of all legal prescription medications.
 
(Click Magnacet Uses for more information, including possible off-label uses of Magnacet.)
 

Who Makes Magnacet?

Brand-name Magnacet is manufactured by Mikart, Inc. and is marketed and distributed by Mallinckrodt Brand Pharmaceuticals, Inc.
 

How Does It Work?

Magnacet contains two different medications (oxycodone and acetaminophen) that work together to control pain. Oxycodone is a semi-synthetic, opioid pain reliever. It is chemically related to codeine. Oxycodone is effective at decreasing pain but also causes drowsiness and suppresses the drive to breathe (which is known medically as "respiratory suppression").
 
Acetaminophen is a pain reliever and fever reducer commonly found in non-prescription medications such as Tylenol®. "APAP" is a commonly used acronym for one of the chemical names for acetaminophen. Adding acetaminophen to oxycodone makes Magnacet more effective at relieving pain.
 
(Magnacet Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;